Evidence map›Paper›PMID 27490530›Full record

ArticleMolecules (Basel, Switzerland)2016

Preparation of Hydrochlorothiazide Nanoparticles for Solubility Enhancement.

Eliska Vaculikova, Aneta Cernikova, Daniela Placha, Martin Pisarcik, Pavlina Peikertova, Katerina Dedkova, Ferdinand Devinsky, Josef Jampilek

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eliska VaculikovaNanotechnology Centre, VSB-Technical University of Ostrava, 17. listopadu 15/2172, 708 33 Ostrava, Czech Republic. eliskavaculikova@seznam.cz.
Aneta CernikovaDepartment of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 612 42 Brno, Czech Republic. cernikova.aneta@gmail.com.
Daniela PlachaNanotechnology Centre, VSB-Technical University of Ostrava, 17. listopadu 15/2172, 708 33 Ostrava, Czech Republic. daniela.placha@vsb.cz.
Martin PisarcikDepartment of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinciakova 8, 832 32 Bratislava, Slovakia. pisarcik@fpharm.uniba.sk.
Pavlina PeikertovaNanotechnology Centre, VSB-Technical University of Ostrava, 17. listopadu 15/2172, 708 33 Ostrava, Czech Republic. pavlina.peikertova@vsb.cz.
Katerina DedkovaNanotechnology Centre, VSB-Technical University of Ostrava, 17. listopadu 15/2172, 708 33 Ostrava, Czech Republic. katerina.dedkova@vsb.cz.
Ferdinand DevinskyDepartment of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinciakova 8, 832 32 Bratislava, Slovakia. devinsky@fpharm.uniba.sk.
Josef JampilekDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 832 32 Bratislava, Slovakia. josef.jampilek@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles can be considered as a useful tool for improving properties of poorly soluble active ingredients. Hydrochlorothiazide (Class IV of the Biopharmaceutical Classification System) was chosen as a model compound. Antisolvent precipitation-solvent evaporation and emulsion solvent evaporation methods were used for preparation of 18 samples containing hydrochlorothiazide nanoparticles. Water solutions of surfactants sodium dodecyl sulfate, Tween 80 and carboxymethyl dextran were used in mass concentrations of 1%, 3% and 5%. Acetone and dichloromethane were used as solvents of the model compound. The particle size of the prepared samples was measured by dynamic light scattering. The selected sample of hydrochlorothiazide nanoparticles stabilized with carboxymethyl dextran sodium salt with particle size 2.6 nm was characterized additionally by Fourier transform mid-infrared spectroscopy and scanning electron microscopy. It was found that the solubility of this sample was 6.5-fold higher than that of bulk hydrochlorothiazide.

Indexed as

Drug CompoundingDynamic Light ScatteringHydrochlorothiazideMolecular StructureNanoparticlesParticle SizeSolubilitySolventsSurface-Active AgentsHydrochlorothiazideSolventsSurface-Active Agentsdynamic light scatteringhydrochlorothiazideinfrared spectroscopynanoparticlesscanning electron microscopysolubility

Identifiers

PMID27490530
PMCPMC6274297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.